3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Ganglioneuroblastoma
3
Breast Neoplasms
3
Neuroblastoma
2
Gliosarcoma
2
Glioblastoma
2
Wilms Tumor
1
Uterine Cervical Neoplasms
1
Thyroid Neoplasms
1
Thyroid Diseases
1
Thyroid Cancer, Papillary
1
Thoracic Diseases
1
Testicular Neoplasms
1
Teratoma
1
Stomach Neoplasms
1
Stage I Prostate Adenocarcinoma AJCC v7
1
Squamous Cell Carcinoma of Head and Neck
1
Skin Neoplasms
1
Seroma
1
Salivary Gland Neoplasms
1
Rhabdomyosarcoma
1
Recurrence
1
Prostatic Neoplasms
1
Polycystic Ovary Syndrome
1
Parathyroid Neoplasms
1
Parathyroid Diseases
1
Pancreatic Neoplasms
1
Ovarian Germ Cell Cancer
1
Neoplasm Metastasis
1
Lymphatic Metastasis
1
Lung Neoplasms
1
Interventions
Sorafenib
42
Bevacizumab
16
Oxaliplatin
13
Radiosurgery
10
Gemcitabine
10
Doxorubicin
10
Capecitabine
10
Leucovorin
9
Hepatectomy
9
Fluorouracil
9
Cisplatin
9
Radiofrequency Ablation
8
Nivolumab
8
pembrolizumab
7
Drug Therapy
7
Carboplatin
7
Irinotecan
6
Cryosurgery
6
Talaporfin
5
Mitomycin
5
Everolimus
5
Erlotinib Hydrochloride
5
Electroporation
5
spartalizumab
4
Sunitinib
4
Melphalan
4
Ipilimumab
4
Epirubicin
4
Embolization, Therapeutic
4
regorafenib
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Liver Neoplasms
×
Congresses as Topic
×
Clear all
NCT02784353
2022-11-17
PReHeBP
Asan Medical Center
Phase NA
Completed
158 enrolled